PH vs RLMD · P/E 28, rev $19.85B vs $692.3M cap
Parker-Hannifin Corporation (PH) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
RLMD does not have a complete income-statement cache yet.
PH currently screens at market cap $91.89B and trailing P/E 27.7. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the PH and RLMD stock pages for the full models.
Not investment advice.